-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Considerations in the design of clinical trials of antibacterial agents for ventilator-associated pneumonia
John Muscedere
Review Article: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation